
Check out our latest #research on ADP-ribosylation signaling, published in@NatureComms and led by our former PhD student @ELongarini! 🥳 nature.com/articles/s41467-0…

We are interested in ADP-ribosylation signaling in the DNA damage response and ageing. Account managed by lab members. @MPIAGE.

Check out our latest #research on ADP-ribosylation signaling, published in@NatureComms and led by our former PhD student @ELongarini! 🥳 nature.com/articles/s41467-0…

We are happy to share that our latest study on ADP-ribosyl-linked serine ubiquitylation in the context of PARP1 signaling and the DNA damage response is out in Nature Chemical Biology! 🥂🎉☺️ nature.com/articles/s41589-0…

These new antibody development efforts align with our vision that the fundamental discovery of Serine ADP-ribosylation can be converted into a technology that transforms the study of ADP-ribosylation and related PTMs.

This preprint is part of a larger manuscript on additional antibodies and their applications to biological questions. The goal of this preprint is to share these poly-ADPr with the community without delay, as we believe they will benefit many laboratories.

As with our other tools, the AbD64138 clone should become widely accessible in a few months. For those familiar with our popular AbD43647 antibody, the new AbD64138 clone provides similar advantages for poly-ADPr as AbD43647 does for mono-ADPr.

We’re particularly excited to share with the community the exceptionally high sensitivity we’ve achieved for poly-ADPr immunoblotting, all while using a faster and simpler protocol enabled by a sophisticated SpyTag-HRP format that eliminates the need for secondary antibodies.

We’ve uploaded a bioRxiv preprint on new antibodies specific for poly-ADP-ribosylation (PARylation). These modular tools were developed and validated through novel applications of our Serine ADP-ribosylation-based technology. biorxiv.org/content/10.1101/…

Welcome to the newly elected EMBO Members Oliver Hobert @Columbia_Bio, Valérie Borde @lab_borde, Lumír Krejci @MasarykUni, Ivan Matić @Lab_Matic, Ewelina Knapska @e_knapska, Steven West @XRNchew, Ita Gruić-Sovulj, Martin Howard @JohnInnesCentre and Paola Scaffidi! #EMBOat60


Great event for RNA aficionados. Samantha will present her PhD project on a lncRNA in podocyte biology.
We invite all #RNA and #epigenetic enthusiasts to join us on 8 November @MPIAGE for our 7th Rhineland RNA Club meeting (sponsored by @RNASociety @lexogen and epi-club CMMS). We have fantastic local speakers and two exciting invited speakers @hilgers_lab and @boettcher_lab !🧑🔬👩🔬👨🔬

Last week we had the pleasure of hosting Professor Lee Kraus from UT Southwestern in Texas. After an insightful talk @MPIAGE and a fruitful round table discussions about science, industry and much in between, we continued our evening in a traditional German restaurant. 🍻

Our new paper describing how tyrosine-linked ADP-ribosylation signalling is reversed. Big thanks to our collaborators @JgmRack, @LeidenADPr and @Lab_Matic. jbc.org/article/S0021-9258(2…

New work in collaboration with @IvanAhelLab , @JgmRack and @Lab_Matic ! Tyr-ADPr solved! Despite its acid sensitivity 🫠

SEMINAR: Discovery and development of Serine ADP-ribosylation, Dr Ivan Matić; Max Planck Institute for Biology of Ageing Tuesday 17th September, 1.30-2.30pm Details: babraham.ac.uk/seminars/2024…

Our new paper demonstrating reversible ubiquitylation of DNA and RNA: embopress.org/doi/full/10.10…

Last week two of our lab members attended the #NADSRC in sunny Lisbon ☀️🌊 Our Serine-ADPr technnology was showcased in a talk by our postdoc Helen, and she and our PhD student Mihaela presented it during two successful poster sessions! ☺️